Among patients with chronic second-degree AV nodal block, those with organic heart disease had higher mortality (43.2%) compared to those without organic heart disease (10.5%).
Cohort (n=56)
Chronic second-degree AV nodal block has a benign course in patients without organic heart disease, whereas prognosis is poor and driven by underlying disease in those with organic heart disease.
Absolute Event Rate: 43.2% vs 10.5%
This report details our experience with documented chronic second-degree atrioventricular (AV) nodal block (proximal to His H) in 56 patients. Forty-six men (82%) and 10 women (18%), ages 18-87 years, were studied. Nineteen of the patients (34%) had no organic heart disease (including seven trained athletes) and 37 (66%) had organic heart disease. ECGs in all patients demonstrated episodes of type I second-degree block; five patients also had periods of 2:1 block. Prospective follow-up patients with no organic heart disease (157-2280 days, mean 1395 +/- 636 days) revealed one patient with clear indication for permanent pacing because of bradyarrhythmic symptoms (permanently placed on day 220 of follow-up). Two patients died nonsuddenly. In patients with organic heart disease (prospective follow-up of 60-2950 days, mean 1347 +/- 825 days), pacemakers were implanted in 10 patients, primarily for treatment of congestive heart failure in eight and syncope in two. Sixteen patients died -- three suddenly, seven with congestive heart failure, two of an acute myocardial infarction and four of causes unrelated to cardiac disease. In summary, chronic second-degree AV nodal block has a relatively benign course in patients without organic heart disease. In patients with organic heart disease, prognosis is poor and related to the severity of underlying heart disease.
Strasberg et al. (Fri,) conducted a cohort in chronic second-degree atrioventricular nodal block (n=56). Organic heart disease vs. No organic heart disease was evaluated on Mortality. Among patients with chronic second-degree AV nodal block, those with organic heart disease had higher mortality (43.2%) compared to those without organic heart disease (10.5%).